Malawi

Malawi

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
6.91 (5.25 - 8.88) 2015 Modelled WHO
3.2 (2.70 - 3.90) 2016 Modelled Razavi-Shearer et al, 2018
12.22 (9.80 - 15.14) 2013 Modelled Schweitzer et al, 2015
7.86 (6.51 - 9.33) 2019 Modelled IHME, GBD 2019 (accessed 2020)
8.45 (6.92 - 10.01) 2018 Modelled IHME, GBD 2019 (accessed 2022)
8.46 (6.78 - 10.16) 2017 Modelled IHME, GBD 2019 (accessed 2022)
9.08 (7.39 - 10.71) 2016 Modelled IHME, GBD 2019 (accessed 2022)
9.67 (7.83 - 11.48) 2015 Modelled IHME, GBD 2019 (accessed 2022)
9.78 (7.92 - 11.56) 2014 Modelled IHME, GBD 2019 (accessed 2022)
10.05 (8.12 - 11.89) 2013 Modelled IHME, GBD 2019 (accessed 2022)
10.38 (8.37 - 12.34) 2012 Modelled IHME, GBD 2019 (accessed 2022)
10.62 (8.53 - 12.72) 2011 Modelled IHME, GBD 2019 (accessed 2022)
10.69 (8.51 - 12.89) 2010 Modelled IHME, GBD 2019 (accessed 2022)
10.77 (8.64 - 12.93) 2009 Modelled IHME, GBD 2019 (accessed 2022)
11.04 (8.94 - 13.18) 2008 Modelled IHME, GBD 2019 (accessed 2022)
11.38 (9.24 - 13.54) 2007 Modelled IHME, GBD 2019 (accessed 2022)
11.67 (9.48 - 13.83) 2006 Modelled IHME, GBD 2019 (accessed 2022)
11.79 (9.60 - 13.95) 2005 Modelled IHME, GBD 2019 (accessed 2022)
11.93 (9.66 - 14.20) 2004 Modelled IHME, GBD 2019 (accessed 2022)
12.26 (9.83 - 14.62) 2003 Modelled IHME, GBD 2019 (accessed 2022)
12.67 (10.17 - 15.27) 2002 Modelled IHME, GBD 2019 (accessed 2022)
13.01 (10.35 - 15.80) 2001 Modelled IHME, GBD 2019 (accessed 2022)
13.17 (10.36 - 16.12) 2000 Modelled IHME, GBD 2019 (accessed 2022)
13.2 (10.50 - 16.12) 1999 Modelled IHME, GBD 2019 (accessed 2022)
13.25 (10.51 - 16.07) 1998 Modelled IHME, GBD 2019 (accessed 2022)
13.3 (10.53 - 16.03) 1997 Modelled IHME, GBD 2019 (accessed 2022)
13.32 (10.58 - 16.09) 1996 Modelled IHME, GBD 2019 (accessed 2022)
13.3 (10.53 - 15.98) 1995 Modelled IHME, GBD 2019 (accessed 2022)
13.21 (10.50 - 15.89) 1994 Modelled IHME, GBD 2019 (accessed 2022)
13.04 (10.44 - 15.63) 1993 Modelled IHME, GBD 2019 (accessed 2022)
12.79 (10.19 - 15.34) 1992 Modelled IHME, GBD 2019 (accessed 2022)
12.47 (9.88 - 15.04) 1991 Modelled IHME, GBD 2019 (accessed 2022)
12.11 (9.60 - 14.68) 1990 Modelled IHME, GBD 2019 (accessed 2022)
8.39 (7 - 9.94) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
3.03 (1.92 - 4.36) 2015 Modelled WHO
1.59 (1.17 - 2.14) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1.81 (1.33 - 2.40) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.88 (1.37 - 2.42) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.9 (1.38 - 2.46) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.86 (1.38 - 2.38) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.81 (1.32 - 2.36) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.79 (1.32 - 2.32) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.75 (1.30 - 2.26) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.71 (1.25 - 2.21) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.68 (1.23 - 2.17) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.67 (1.21 - 2.16) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.69 (1.23 - 2.18) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.74 (1.27 - 2.25) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.84 (1.34 - 2.39) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.96 (1.42 - 2.58) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.12 (1.50 - 2.81) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.08 (2.21 - 4.07) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5.13 (3.70 - 6.72) 2003 Modelled IHME, GBD 2019 (accessed 2022)
7.51 (5.45 - 9.83) 2002 Modelled IHME, GBD 2019 (accessed 2022)
9.5 (6.92 - 12.57) 2001 Modelled IHME, GBD 2019 (accessed 2022)
10.38 (7.51 - 13.72) 2000 Modelled IHME, GBD 2019 (accessed 2022)
10.45 (7.61 - 13.75) 1999 Modelled IHME, GBD 2019 (accessed 2022)
10.48 (7.81 - 13.79) 1998 Modelled IHME, GBD 2019 (accessed 2022)
10.48 (7.79 - 13.69) 1997 Modelled IHME, GBD 2019 (accessed 2022)
10.45 (7.76 - 13.73) 1996 Modelled IHME, GBD 2019 (accessed 2022)
10.42 (7.65 - 13.79) 1995 Modelled IHME, GBD 2019 (accessed 2022)
10.34 (7.66 - 13.46) 1994 Modelled IHME, GBD 2019 (accessed 2022)
10.17 (7.52 - 13.16) 1993 Modelled IHME, GBD 2019 (accessed 2022)
9.92 (7.31 - 12.80) 1992 Modelled IHME, GBD 2019 (accessed 2022)
9.63 (7.05 - 12.44) 1991 Modelled IHME, GBD 2019 (accessed 2022)
9.31 (6.76 - 12.09) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.39 (1.08 - 1.78) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
585,000 (488,000 - 711,000) 2016 Modelled Razavi-Shearer et al, 2018
1,448,870 (1,200,080 - 1,719,880) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1,484,720 (1,231,180 - 1,759,910) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1,455,570 (1,191,440 - 1,726,410) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1,417,700 (1,140,250 - 1,702,460) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,480,990 (1,205,320 - 1,748,710) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,535,610 (1,246,090 - 1,818,830) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,509,950 (1,222,500 - 1,786,370) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,511,810 (1,222,060 - 1,788,040) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1,519,590 (1,226,990 - 1,804,740) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1,514,960 (1,215,520 - 1,813,370) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1,482,830 (1,181,600 - 1,788,840) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1,452,410 (1,165,130 - 1,742,630) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1,448,630 (1,173,520 - 1,728,030) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,454,190 (1,180,800 - 1,730,460) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1,453,940 (1,183,330 - 1,724,610) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,433,620 (1,164,810 - 1,697,220) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1,416,650 (1,149,460 - 1,683,200) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1,424,070 (1,142,790 - 1,700,160) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,439,390 (1,153,720 - 1,732,850) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1,446,330 (1,149,630 - 1,757,480) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1,430,350 (1,124,580 - 1,751,830) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1,400,840 (1,115,230 - 1,707,850) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1,373,760 (1,090,510 - 1,664,540) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1,346,560 (1,066,310 - 1,622,150) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1,317,300 (1,047,540 - 1,594,660) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1,284,490 (1,014,550 - 1,544,250) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1,268,820 (1,009,760 - 1,525,470) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1,279,280 (1,020,820 - 1,535,960) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,266,510 (1,009,860 - 1,522,850) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1,208,690 (956,676 - 1,456,990) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1,133,840 (897,106 - 1,376,070) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.86 (2.60 - 5.40) 2019 Modelled IHME, GBD 2019 (accessed 2020)
8.9 (6.21 - 12.25) 1990 Modelled IHME, GBD 2019 (accessed 2022)
8.81 (6.16 - 12.19) 1991 Modelled IHME, GBD 2019 (accessed 2022)
8.82 (6.15 - 12.09) 1992 Modelled IHME, GBD 2019 (accessed 2022)
8.97 (6.28 - 12.29) 1993 Modelled IHME, GBD 2019 (accessed 2022)
9.44 (6.67 - 12.73) 1995 Modelled IHME, GBD 2019 (accessed 2022)
9.28 (6.53 - 12.71) 1994 Modelled IHME, GBD 2019 (accessed 2022)
9.5 (6.74 - 12.91) 1996 Modelled IHME, GBD 2019 (accessed 2022)
9.48 (6.83 - 12.81) 1997 Modelled IHME, GBD 2019 (accessed 2022)
9.55 (6.87 - 12.92) 1998 Modelled IHME, GBD 2019 (accessed 2022)
9.45 (6.83 - 12.56) 1999 Modelled IHME, GBD 2019 (accessed 2022)
9.26 (6.69 - 12.26) 2000 Modelled IHME, GBD 2019 (accessed 2022)
8.82 (6.35 - 11.83) 2001 Modelled IHME, GBD 2019 (accessed 2022)
8.38 (6.02 - 11.23) 2002 Modelled IHME, GBD 2019 (accessed 2022)
8 (5.81 - 10.53) 2003 Modelled IHME, GBD 2019 (accessed 2022)
7.67 (5.55 - 10.13) 2004 Modelled IHME, GBD 2019 (accessed 2022)
7.37 (5.32 - 9.82) 2005 Modelled IHME, GBD 2019 (accessed 2022)
7.09 (5.12 - 9.41) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6.63 (4.81 - 8.85) 2008 Modelled IHME, GBD 2019 (accessed 2022)
6.84 (4.92 - 9.11) 2007 Modelled IHME, GBD 2019 (accessed 2022)
6.5 (4.73 - 8.64) 2009 Modelled IHME, GBD 2019 (accessed 2022)
6.44 (4.72 - 8.60) 2010 Modelled IHME, GBD 2019 (accessed 2022)
6.02 (4.31 - 8.05) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5.37 (3.82 - 7.26) 2012 Modelled IHME, GBD 2019 (accessed 2022)
4.7 (3.28 - 6.53) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4.17 (2.90 - 5.86) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3.93 (2.70 - 5.56) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3.93 (2.68 - 5.51) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3.9 (2.65 - 5.42) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3.96 (2.69 - 5.53) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3.86 (2.60 - 5.40) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
687 2016 Modelled WHO
850 (593 - 1,170) 1990 Modelled IHME, GBD 2019 (accessed 2022)
871 (609 - 1,205) 1991 Modelled IHME, GBD 2019 (accessed 2022)
896 (628 - 1,228) 1993 Modelled IHME, GBD 2019 (accessed 2022)
890 (621 - 1,220) 1992 Modelled IHME, GBD 2019 (accessed 2022)
928 (656 - 1,252) 1995 Modelled IHME, GBD 2019 (accessed 2022)
957 (679 - 1,301) 1996 Modelled IHME, GBD 2019 (accessed 2022)
907 (638 - 1,242) 1994 Modelled IHME, GBD 2019 (accessed 2022)
979 (705 - 1,322) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1,010 (726 - 1,366) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1,027 (742 - 1,360) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1,024 (740 - 1,360) 1999 Modelled IHME, GBD 2019 (accessed 2022)
975 (701 - 1,306) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1,002 (721 - 1,344) 2001 Modelled IHME, GBD 2019 (accessed 2022)
952 (692 - 1,254) 2003 Modelled IHME, GBD 2019 (accessed 2022)
936 (677 - 1,236) 2004 Modelled IHME, GBD 2019 (accessed 2022)
908 (655 - 1,205) 2006 Modelled IHME, GBD 2019 (accessed 2022)
922 (665 - 1,228) 2005 Modelled IHME, GBD 2019 (accessed 2022)
895 (650 - 1,195) 2008 Modelled IHME, GBD 2019 (accessed 2022)
903 (657 - 1,199) 2009 Modelled IHME, GBD 2019 (accessed 2022)
899 (647 - 1,197) 2007 Modelled IHME, GBD 2019 (accessed 2022)
885 (633 - 1,183) 2011 Modelled IHME, GBD 2019 (accessed 2022)
920 (674 - 1,229) 2010 Modelled IHME, GBD 2019 (accessed 2022)
812 (577 - 1,099) 2012 Modelled IHME, GBD 2019 (accessed 2022)
732 (512 - 1,018) 2013 Modelled IHME, GBD 2019 (accessed 2022)
650 (446 - 919) 2015 Modelled IHME, GBD 2019 (accessed 2022)
668 (456 - 937) 2016 Modelled IHME, GBD 2019 (accessed 2022)
669 (465 - 941) 2014 Modelled IHME, GBD 2019 (accessed 2022)
691 (470 - 966) 2017 Modelled IHME, GBD 2019 (accessed 2022)
701 (476 - 973) 2018 Modelled IHME, GBD 2019 (accessed 2022)
713 (480 - 996) 2019 Modelled IHME, GBD 2019 (accessed 2022)
713 (480 - 996) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
3 (2 - 4) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 5) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 3) 2006 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2007 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2009 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2008 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2010 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2012 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2014 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 6) 2016 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2015 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2017 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 7) 2018 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 7) 2019 Modelled IHME, GBD 2019 (accessed 2022)
25 (19 - 33) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
95 2019 Survey/reported WHO/UNICEF
90 2020 Survey/reported WHO/UNICEF
93 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.69 (1.35 - 2.09) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.68 (1.35 - 2.11) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.68 (1.34 - 2.10) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.68 (1.34 - 2.09) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.67 (1.34 - 2.10) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.68 (1.34 - 2.09) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.69 (1.34 - 2.10) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.7 (1.36 - 2.12) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.72 (1.37 - 2.15) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.74 (1.38 - 2.17) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.76 (1.41 - 2.21) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.79 (1.43 - 2.23) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.82 (1.46 - 2.27) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.85 (1.48 - 2.30) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.87 (1.50 - 2.34) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.89 (1.53 - 2.37) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.91 (1.54 - 2.38) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.92 (1.55 - 2.38) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.94 (1.57 - 2.41) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.95 (1.57 - 2.44) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.96 (1.59 - 2.45) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.98 (1.60 - 2.45) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.99 (1.61 - 2.46) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.01 (1.62 - 2.48) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.02 (1.63 - 2.49) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.02 (1.63 - 2.50) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.01 (1.63 - 2.50) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2 (1.62 - 2.49) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.01 (1.61 - 2.49) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.01 (1.61 - 2.50) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.61 (1.29 - 2) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
People living with HIV (PLHIV)
Download
Value (%) Year Type Source
5.7 (3.60 - 8.90) 2005 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
0 (0 - 1.70) 2014 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
Showing out of
Show more
Pregnant women living with HIV
Download
Value (%) Year Type Source
12 (5.60 - 23.80) 1994 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.82 (0.63 - 1.09) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
7.3 (0 - 24.30) 2018 Modelled Epidemiology of hepatitis B, C and D in Malawi: systematic review
Pregnant women
Download
Value (%) Year Type Source
2.9 (0.80 - 9.80) 1992 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
18 (11.70 - 26.70) 1994 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
5.8 (3 - 11) 2006 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
Showing out of
Show more
People living with HIV (PLHIV)
Download
Value (%) Year Type Source
0.5 (0.10 - 1.90) 2015 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
10 (7 - 14.10) 1998 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
2.2 (0.90 - 5.10) 2014 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
Showing out of
Show more
Pregnant women living with HIV
Download
Value (%) Year Type Source
0.7 (0.10 - 3.90) 2001 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
2.6 (1.30 - 5) 2008 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
0.3 (0.10 - 1.80) 2008 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
5.4 (2.80 - 10.30) 2002 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
Showing out of
Show more
Prisoners
Download
Value (%) Year Type Source
0 (0 - 2.30) 2007 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
188,462 (150,335 - 234,380) 1990 Modelled IHME, GBD 2019 (accessed 2022)
194,544 (156,271 - 241,308) 1991 Modelled IHME, GBD 2019 (accessed 2022)
198,518 (159,949 - 246,659) 1992 Modelled IHME, GBD 2019 (accessed 2022)
197,163 (159,544 - 245,165) 1993 Modelled IHME, GBD 2019 (accessed 2022)
193,721 (156,637 - 240,554) 1994 Modelled IHME, GBD 2019 (accessed 2022)
194,591 (157,108 - 241,498) 1995 Modelled IHME, GBD 2019 (accessed 2022)
198,316 (160,528 - 245,268) 1996 Modelled IHME, GBD 2019 (accessed 2022)
201,808 (163,705 - 250,177) 1997 Modelled IHME, GBD 2019 (accessed 2022)
205,090 (165,823 - 253,995) 1998 Modelled IHME, GBD 2019 (accessed 2022)
208,313 (168,273 - 259,304) 1999 Modelled IHME, GBD 2019 (accessed 2022)
211,674 (170,871 - 264,156) 2000 Modelled IHME, GBD 2019 (accessed 2022)
215,120 (173,852 - 268,390) 2001 Modelled IHME, GBD 2019 (accessed 2022)
218,433 (175,898 - 271,197) 2002 Modelled IHME, GBD 2019 (accessed 2022)
221,609 (178,573 - 276,330) 2003 Modelled IHME, GBD 2019 (accessed 2022)
224,782 (180,827 - 281,296) 2004 Modelled IHME, GBD 2019 (accessed 2022)
227,946 (181,483 - 284,457) 2005 Modelled IHME, GBD 2019 (accessed 2022)
230,696 (184,068 - 287,539) 2006 Modelled IHME, GBD 2019 (accessed 2022)
232,991 (187,095 - 291,415) 2007 Modelled IHME, GBD 2019 (accessed 2022)
235,247 (188,525 - 293,583) 2008 Modelled IHME, GBD 2019 (accessed 2022)
237,836 (189,894 - 298,128) 2009 Modelled IHME, GBD 2019 (accessed 2022)
241,122 (191,834 - 301,118) 2010 Modelled IHME, GBD 2019 (accessed 2022)
244,897 (196,035 - 305,633) 2011 Modelled IHME, GBD 2019 (accessed 2022)
248,896 (199,468 - 311,921) 2012 Modelled IHME, GBD 2019 (accessed 2022)
253,447 (201,849 - 317,059) 2013 Modelled IHME, GBD 2019 (accessed 2022)
258,972 (206,216 - 323,180) 2014 Modelled IHME, GBD 2019 (accessed 2022)
265,889 (212,384 - 333,009) 2015 Modelled IHME, GBD 2019 (accessed 2022)
273,571 (218,781 - 341,070) 2016 Modelled IHME, GBD 2019 (accessed 2022)
281,708 (224,874 - 352,058) 2017 Modelled IHME, GBD 2019 (accessed 2022)
290,191 (232,928 - 363,791) 2018 Modelled IHME, GBD 2019 (accessed 2022)
298,676 (239,354 - 372,011) 2019 Modelled IHME, GBD 2019 (accessed 2022)
296,392 (237,156 - 369,415) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
37,300 (28,700 - 49,400) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
7.6 (5.47 - 10.10) 2019 Modelled IHME, GBD 2019 (accessed 2020)
10.01 (7.39 - 12.93) 1990 Modelled IHME, GBD 2019 (accessed 2022)
9.93 (7.24 - 12.81) 1991 Modelled IHME, GBD 2019 (accessed 2022)
9.96 (7.30 - 12.91) 1992 Modelled IHME, GBD 2019 (accessed 2022)
10.16 (7.42 - 13.14) 1993 Modelled IHME, GBD 2019 (accessed 2022)
10.7 (7.99 - 13.85) 1995 Modelled IHME, GBD 2019 (accessed 2022)
10.54 (7.75 - 13.62) 1994 Modelled IHME, GBD 2019 (accessed 2022)
10.72 (8.12 - 13.83) 1997 Modelled IHME, GBD 2019 (accessed 2022)
10.73 (8.11 - 13.82) 1996 Modelled IHME, GBD 2019 (accessed 2022)
10.79 (8.11 - 14.04) 1998 Modelled IHME, GBD 2019 (accessed 2022)
10.67 (8 - 13.90) 1999 Modelled IHME, GBD 2019 (accessed 2022)
10.48 (7.96 - 13.62) 2000 Modelled IHME, GBD 2019 (accessed 2022)
9.94 (7.61 - 12.88) 2002 Modelled IHME, GBD 2019 (accessed 2022)
10.15 (7.75 - 13.26) 2001 Modelled IHME, GBD 2019 (accessed 2022)
9.75 (7.40 - 12.67) 2003 Modelled IHME, GBD 2019 (accessed 2022)
9.57 (7.23 - 12.40) 2004 Modelled IHME, GBD 2019 (accessed 2022)
9.29 (6.94 - 11.92) 2005 Modelled IHME, GBD 2019 (accessed 2022)
8.96 (6.78 - 11.50) 2006 Modelled IHME, GBD 2019 (accessed 2022)
8.37 (6.43 - 10.82) 2008 Modelled IHME, GBD 2019 (accessed 2022)
8.65 (6.56 - 11.11) 2007 Modelled IHME, GBD 2019 (accessed 2022)
8.2 (6.26 - 10.57) 2009 Modelled IHME, GBD 2019 (accessed 2022)
8.11 (6.22 - 10.41) 2010 Modelled IHME, GBD 2019 (accessed 2022)
7.84 (5.97 - 10.15) 2011 Modelled IHME, GBD 2019 (accessed 2022)
7.65 (5.76 - 9.93) 2012 Modelled IHME, GBD 2019 (accessed 2022)
7.56 (5.58 - 9.92) 2015 Modelled IHME, GBD 2019 (accessed 2022)
7.57 (5.63 - 9.88) 2013 Modelled IHME, GBD 2019 (accessed 2022)
7.56 (5.62 - 9.92) 2014 Modelled IHME, GBD 2019 (accessed 2022)
7.6 (5.60 - 9.92) 2016 Modelled IHME, GBD 2019 (accessed 2022)
7.71 (5.66 - 10.22) 2017 Modelled IHME, GBD 2019 (accessed 2022)
7.64 (5.54 - 10.12) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7.6 (5.47 - 10.05) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
445 2016 Modelled WHO
1,402 (1,008 - 1,854) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1,402 (1,008 - 1,854) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1,371 (994 - 1,817) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1,348 (989 - 1,785) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,292 (952 - 1,687) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,250 (922 - 1,639) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,213 (901 - 1,592) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,179 (877 - 1,540) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1,158 (871 - 1,502) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1,152 (877 - 1,492) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1,158 (888 - 1,487) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1,138 (870 - 1,468) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1,131 (869 - 1,461) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,137 (863 - 1,461) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1,148 (869 - 1,474) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,161 (867 - 1,490) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1,167 (882 - 1,513) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1,161 (881 - 1,508) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,156 (885 - 1,498) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1,153 (880 - 1,506) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1,163 (883 - 1,511) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1,156 (866 - 1,506) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1,141 (858 - 1,485) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1,106 (838 - 1,427) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1,080 (817 - 1,392) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1,052 (785 - 1,361) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1,030 (757 - 1,331) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1,015 (741 - 1,313) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,005 (737 - 1,303) 1992 Modelled IHME, GBD 2019 (accessed 2022)
982 (715 - 1,266) 1991 Modelled IHME, GBD 2019 (accessed 2022)
956 (707 - 1,235) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
2 (1 - 3) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 2) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 3) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 3) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 3) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 3) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 3) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 3) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 3) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 3) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 2) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 3) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 2) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 2) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 2) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 2) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 2) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 2) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 3) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2 (1 - 3) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2 (2 - 3) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2012 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2014 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 5) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 2015 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 5) 2018 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2019 Modelled IHME, GBD 2019 (accessed 2022)
19 (13 - 25) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
7.86 (%)
2019
(6.51 - 9.33(%))
IHME, GBD 2019 (accessed 2020)
HCV (RNA/cAg+)
1.61 (%)
2019
(1.29 - 2(%))
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
713
2019
(480 - 996)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
1,402
2019
(1,008 - 1,854)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
1.39 (%)
2020, latest modelled
(1.08 - 1.78(%))
WHO

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

News

Resources

Programs